Your browser doesn't support javascript.
loading
HER2-Low Breast Cancer: a New Subtype?
Corti, Chiara; Giugliano, Federica; Nicolò, Eleonora; Tarantino, Paolo; Criscitiello, Carmen; Curigliano, Giuseppe.
Afiliação
  • Corti C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy. chiara.corti@ieo.it.
  • Giugliano F; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy. chiara.corti@ieo.it.
  • Nicolò E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
  • Tarantino P; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy.
  • Criscitiello C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
  • Curigliano G; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy.
Curr Treat Options Oncol ; 24(5): 468-478, 2023 05.
Article em En | MEDLINE | ID: mdl-36971965
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados / Neoplasias de Mama Triplo Negativas Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados / Neoplasias de Mama Triplo Negativas Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article